Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Non-Current Deffered Revenue (2025)

Camp4 Therapeutics (CAMP) has disclosed Non-Current Deffered Revenue for 1 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue changed N/A to $8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $8.1 million for FY2025, N/A changed from the prior year.
  • Non-Current Deffered Revenue hit $8.1 million in Q4 2025 for Camp4 Therapeutics.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $8.1 million in Q4 2025 to a low of $8.1 million in Q4 2025.